McCall Thomas D 4
4 · ICU MEDICAL INC/DE · Filed Aug 27, 2018
Insider Transaction Report
Form 4
McCall Thomas D
Other
Transactions
- Exercise of In-Money
Common Stock
2018-08-23$58.79/sh+827$48,619→ 3,018 total - Exercise of In-Money
Common Stock
2018-08-23$60.40/sh+209$12,624→ 2,191 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-08-23−563→ 0 totalExercise: $61.76Exp: 2023-02-06→ Common Stock (563 underlying) - Sale
Common Stock
2018-08-23$300.34/sh−1,599$480,244→ 1,419 total - Exercise of In-Money
Common Stock
2018-08-24$58.79/sh+2,142$125,928→ 11,725 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-08-24−7,392→ 0 totalExercise: $88.76Exp: 2025-02-11→ Common Stock (7,392 underlying) - Sale
Common Stock
2018-08-24$303.45/sh−2,901$880,308→ 2,191 total - Exercise of In-Money
Common Stock
2018-08-24$88.76/sh+7,392$656,114→ 9,583 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-08-23−827→ 2,142 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (827 underlying) - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-08-23−209→ 0 totalExercise: $60.40Exp: 2022-10-11→ Common Stock (209 underlying) - Exercise of In-Money
Common Stock
2018-08-23$61.76/sh+563$34,771→ 1,982 total - Sale
Common Stock
2018-08-24$302.70/sh−6,633$2,007,809→ 5,092 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-08-24−2,142→ 0 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (2,142 underlying)
Footnotes (5)
- [F1]The price recorded in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $300.00 to $301.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $302.35 to $303.30, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $303.38 to $303.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F4]Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
- [F5]Options exercisable one-third annually over the first three anniversaries of the grant date.